Sign in

Vir Biotechnology, Inc.

Income Statement - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.07 0.07 0.09 1.62 1.10 0.08 0.00 0.00 0.00
Cost of revenue 0.01 0.48 0.57 0.62 0.51 0.30 0.14 0.10 0.06
Gross profit 0.06 -0.40 -0.49 0.99 0.58 0.08 0.00 -0.10 -0.06
Total operating expenses + 0.52 0.18 0.20 0.16 0.16 0.37 0.18 0.12 0.08
Operating income -0.47 -0.59 -0.68 0.83 0.42 -0.30 -0.18 -0.12 -0.08
Non-operating income (net) 0.03 0.06 0.06 -0.08 0.13 0.00 0.00 0.00 0.00
Income before tax -0.44 -0.52 -0.63 0.75 0.55 -0.30 -0.17 -0.12 -0.08
Income tax expense 0.00 0.00 -0.01 0.24 0.02 0.00 0.00 0.00 -0.01
Net income -0.44 -0.52 -0.62 0.52 0.53 -0.30 -0.17 -0.12 -0.07
Show Quarterly Income Statement

Income Statement - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.00 0.06 0.00 0.00 0.00 0.01 0.00 0.00 0.06 0.02 0.00 0.00 0.06 0.05 0.37 -0.04 1.23 0.81 0.10 0.18 0.00 0.00 0.00 0.07 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 -0.37 0.15 0.10 0.12 0.09 0.20 0.11 0.10 0.11 0.15 0.17 0.16 0.16 0.14 0.14 0.18 0.19 0.11 0.09 0.13 0.00 0.07 0.08 0.06 0.05 0.04 0.03 0.03 0.02 0.03 0.02 0.02
Gross profit 0.00 0.43 -0.15 -0.10 -0.11 -0.08 -0.19 -0.10 -0.04 -0.09 -0.14 -0.16 -0.10 -0.11 0.24 -0.18 1.05 0.63 0.00 0.09 0.00 0.00 0.00 0.07 -0.05 -0.05 -0.04 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02
Total operating expenses + 0.13 0.47 0.02 0.02 0.02 0.04 0.04 0.06 0.04 0.05 0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.06 0.05 0.03 0.16 0.11 0.09 0.10 0.02 0.01 0.05 0.04 0.03 0.03 0.03 0.01 0.01
Operating income -0.13 -0.04 -0.17 -0.12 -0.14 -0.12 -0.23 -0.16 -0.08 -0.14 -0.19 -0.22 -0.14 -0.15 0.19 -0.23 1.01 0.57 -0.05 0.06 -0.16 -0.11 -0.09 -0.03 -0.07 -0.06 -0.05 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03
Non-operating income (net) 0.01 -0.01 0.01 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.00 0.02 -0.01 -0.09 -0.03 0.16 0.00 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.13 -0.04 -0.16 -0.11 -0.12 -0.10 -0.21 -0.14 -0.07 -0.12 -0.17 -0.20 -0.14 -0.15 0.22 -0.23 0.92 0.55 0.11 0.06 -0.17 -0.11 -0.08 -0.03 -0.08 -0.06 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 0.04 -0.16 0.40 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.13 -0.04 -0.16 -0.11 -0.12 -0.10 -0.21 -0.14 -0.07 -0.12 -0.16 -0.19 -0.14 -0.10 0.18 -0.08 0.52 0.53 0.11 0.06 -0.17 -0.11 -0.08 -0.03 -0.08 -0.06 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03
5 days ago

Balance Sheet - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.46 0.91 1.52 2.40 0.71 0.74 0.38 0.10 0.19
Accounts receivable, net 0.00 0.01 0.01 0.03 0.77 0.00
Inventories 0.01 0.00 0.00
Other current assets 0.05 0.14 0.07 0.12 0.08 0.04 0.01 0.02 0.00
Total current assets 0.51 1.04 1.59 2.52 1.56 0.77 0.40 0.12 0.19
Total non-current assets + 0.49 0.36 0.33 0.28 0.39 0.15 0.11 0.07 0.06
Total assets 1.00 1.40 1.92 2.80 1.95 0.92 0.51 0.19 0.25
Total current liabilities + 0.09 0.12 0.18 0.51 0.34 0.10 0.06 0.04 0.01
Total non-current liabilities + 0.14 0.13 0.15 0.21 0.18 0.10 0.03 0.33 0.31
Total liabilities 0.24 0.25 0.33 0.72 0.52 0.20 0.09 0.37 0.32
Total stockholders' equity + 0.77 1.15 1.59 2.08 1.43 0.72 0.42 -0.18 -0.07
Common shares outstanding 139 136 134 135 133 119 108 97 7
Show Quarterly Balance Sheet

Balance Sheet - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 0.47 0.46 0.51 0.61 0.80 0.91 0.91 1.15 1.15 1.52 1.70 1.85 2.25 2.40 2.35 2.20 1.26 0.71 0.94 0.83 0.73 0.74 0.83 0.55 0.36 0.38 0.32 0.36 0.10 0.10 0.00 0.00 0.19
Accounts receivable, net 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.02 0.03 0.01 0.01 1.22 0.77 0.09 0.00 0.23 0.00 0.00 0.00 0.00 0.00
Inventories -0.01 0.00 0.01 0.00 -0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Other current assets 0.05 0.05 0.04 0.13 0.13 0.13 0.13 0.05 0.06 0.07 0.07 0.10 0.11 0.12 0.07 0.09 0.08 0.08 0.03 0.04 0.04 0.04 0.02 0.03 0.02 0.01 0.01 0.02 0.01 0.02 0.00
Total current assets 0.52 0.51 0.55 0.74 0.93 1.04 1.05 1.21 1.21 1.59 1.77 1.95 2.36 2.52 2.41 2.29 2.57 1.56 1.07 0.86 0.99 0.77 0.85 0.58 0.38 0.40 0.34 0.38 0.10 0.12 0.19
Total non-current assets + 0.50 0.49 0.47 0.46 0.38 0.36 0.45 0.46 0.58 0.33 0.28 0.30 0.31 0.28 0.28 0.33 0.32 0.39 0.14 0.20 0.14 0.15 0.09 0.09 0.10 0.11 0.08 0.08 -0.10 0.07 -0.19
Total assets 1.03 1.00 1.02 1.19 1.31 1.40 1.50 1.67 1.79 1.92 2.04 2.24 2.67 2.80 2.70 2.62 2.89 1.95 1.21 1.06 1.14 0.92 0.94 0.67 0.48 0.51 0.42 0.46 0.46 0.19 0.00
Total current liabilities + 0.07 0.09 0.08 0.11 0.14 0.12 0.12 0.10 0.09 0.18 0.17 0.23 0.49 0.51 0.31 0.48 0.70 0.34 0.23 0.15 0.36 0.10 0.08 0.05 0.06 0.06 0.04 0.04 0.04 0.04 0.00
Total non-current liabilities + 0.14 0.14 0.15 0.14 0.13 0.13 0.14 0.14 0.15 0.15 0.20 0.21 0.21 0.21 0.24 0.19 0.18 0.18 0.10 0.17 0.12 0.10 0.05 0.05 0.04 0.03 0.66 0.01 0.00 0.33 0.00
Total liabilities 0.21 0.24 0.22 0.25 0.26 0.25 0.26 0.24 0.25 0.33 0.37 0.43 0.70 0.72 0.55 0.67 0.89 0.52 0.33 0.32 0.48 0.20 0.13 0.11 0.10 0.09 0.70 0.06 0.06 0.37 0.00
Total stockholders' equity + 0.81 0.77 0.80 0.95 1.04 1.15 1.24 1.43 1.55 1.59 1.68 1.81 1.97 2.08 2.15 1.95 2.00 1.43 0.88 0.74 0.65 0.72 0.81 0.56 0.38 0.42 -0.28 0.40 0.13 -0.18 0.22
Common shares outstanding 147 139 139 138 137 137 137 136 135 135 134 134 134 133 135 132 135 134 134 134 128 127 126 115 108 92 109 109 97 97 97 7 7
5 days ago

Cash Flow - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + -0.39 -0.45 -0.78 1.66 -0.05 -0.19 -0.13 -0.09 -0.07
Cash flow from investing + 0.31 0.50 0.16 -1.19 -0.14 -0.01 -0.26 -0.06 -0.03
Cash flow from financing + 0.00 0.00 0.01 0.03 0.10 0.53 0.45 0.02 0.27
Change in cash -0.08 0.06 -0.61 0.50 -0.09 0.33 0.06 -0.13 0.17
Change in exchange rate 0.00 0.00
Show Quarterly Cash Flow

Cash Flow - Vir Biotechnology, Inc. (VIR)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + -0.13 -0.03 -0.17 -0.12 -0.08 -0.09 -0.17 -0.08 -0.11 -0.11 -0.16 -0.39 -0.13 0.04 0.12 0.96 0.55 0.01 -0.11 0.14 -0.09 -0.08 -0.05 -0.01 -0.05 -0.04 -0.04 -0.02 -0.03 -0.03 -0.03 -0.01 -0.01
Cash flow from investing + 0.01 0.09 0.04 0.06 0.13 0.14 0.12 0.21 0.03 -0.10 -0.06 0.23 0.10 -0.15 -0.66 -0.27 -0.11 -0.38 0.07 0.08 0.09 0.06 -0.19 0.01 0.10 -0.07 0.05 0.04 -0.27 0.02 0.02 -0.05 -0.05
Cash flow from financing + 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.01 0.00 0.00 0.09 0.00 0.32 0.21 0.00 0.13 0.00 0.00 0.32 0.01 0.00 0.01 0.01
Change in cash 0.04 0.06 -0.13 -0.06 0.05 0.05 -0.05 0.14 -0.08 -0.21 -0.21 -0.16 -0.03 -0.12 -0.54 0.69 0.47 -0.36 -0.03 0.22 0.09 -0.02 0.09 0.21 0.06 0.02 0.01 0.02 0.01 0.00 -0.01 -0.06 -0.06
Change in exchange rate 0.00 0.00 0.00 0.00
5 days ago

Vir Biotechnology, Inc. (VIR) - Costof Goods And Services Sold

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Cost Of Revenue

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Total Revenue

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Gross Profit

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Other Non Operating Income

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Interest Expense

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Net Income

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Ebitda

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Ebit

1Y 2Y 5Y Max
9 days ago

Vir Biotechnology, Inc. (VIR) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago